Literature DB >> 10348775

Emergence in france of multiple clones of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillin.

C Doit1, C Loukil, F Fitoussi, P Geslin, E Bingen.   

Abstract

The genetic relatedness of French isolates of Streptococcus pneumoniae highly resistant to amoxicillin (MIC, >/=4 microg/ml, equal to or exceeding those of penicillin) was investigated by molecular fingerprinting. The results suggest that high-level resistance to amoxicillin has emerged within preexisting penicillin-resistant clones.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10348775      PMCID： PMC89301          DOI： 10.1128/AAC.43.6.1480

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  Genetics of resistance to third-generation cephalosporins in clinical isolates of Streptococcus pneumoniae.

Authors:  R Muñoz; C G Dowson; M Daniels; T J Coffey; C Martin; R Hakenbeck; B G Spratt
Journal:  Mol Microbiol       Date:  1992-09       Impact factor: 3.501

2.  High-level beta-lactam resistance in strains of Streptococcus pneumoniae isolated in the UK.

Authors:  A P Johnson; D M Livermore; N Woodford; A Quoraishi; R Freeman
Journal:  J Antimicrob Chemother       Date:  1998-07       Impact factor: 5.790

3.  Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s.

Authors:  S Soares; K G Kristinsson; J M Musser; A Tomasz
Journal:  J Infect Dis       Date:  1993-07       Impact factor: 5.226

4.  In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis.

Authors:  C P Doit; S P Bonacorsi; A J Fremaux; G Sissia; R Cohen; P L Geslin; E H Bingen
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

5.  Diminished activity of ceftizoxime in comparison to cefotaxime and ceftriaxone against Streptococcus pneumoniae.

Authors:  D W Haas; C W Stratton; J P Griffin; L Weeks; S C Alls
Journal:  Clin Infect Dis       Date:  1995-03       Impact factor: 9.079

6.  Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci.

Authors:  G A Pankuch; M R Jacobs; P C Appelbaum
Journal:  J Antimicrob Chemother       Date:  1995-06       Impact factor: 5.790

7.  Relatively penicillin-resistant pneumococcal infections in pediatric patients.

Authors:  M A Jackson; S Shelton; J D Nelson; G H McCracken
Journal:  Pediatr Infect Dis       Date:  1984 Mar-Apr

8.  Horizontal transfer of multiple penicillin-binding protein genes, and capsular biosynthetic genes, in natural populations of Streptococcus pneumoniae.

Authors:  T J Coffey; C G Dowson; M Daniels; J Zhou; C Martin; B G Spratt; J M Musser
Journal:  Mol Microbiol       Date:  1991-09       Impact factor: 3.501

9.  Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae.

Authors:  R Muñoz; T J Coffey; M Daniels; C G Dowson; G Laible; J Casal; R Hakenbeck; M Jacobs; J M Musser; B G Spratt
Journal:  J Infect Dis       Date:  1991-08       Impact factor: 5.226

10.  Analysis of DNA restriction fragment length polymorphism extends the evidence for breast milk transmission in Streptococcus agalactiae late-onset neonatal infection.

Authors:  E Bingen; E Denamur; N Lambert-Zechovsky; Y Aujard; N Brahimi; P Geslin; J Elion
Journal:  J Infect Dis       Date:  1992-03       Impact factor: 5.226
View more
  17 in total

1.  Killing activities of trovafloxacin alone and in combination with beta-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically achievable in cerebrospinal fluid.

Authors:  F Fitoussi; C Doit; P Geslin; E Bingen
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

2.  Genetic relatedness of recently collected Spanish respiratory tract Streptococcus pneumoniae isolates with reduced susceptibility to amoxicillin.

Authors:  E Pérez-Trallero; J M Marimón; A González; C García-Rey; L Aguilar
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

3.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

4.  Efficacy of linezolid in experimental otitis media.

Authors:  S I Pelton; M Figueira; R Albut; D Stalker
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

5.  Analysis of penicillin-binding protein genes of clinical isolates of Streptococcus pneumoniae with reduced susceptibility to amoxicillin.

Authors:  Mignon du Plessis; Edouard Bingen; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

6.  Alterations of penicillin-binding proteins 1A, 2X, and 2B in Streptococcus pneumoniae isolates for which amoxicillin MICs are higher than penicillin MICs.

Authors:  K Kosowska; M R Jacobs; S Bajaksouzian; L Koeth; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

7.  In vitro antimicrobial susceptibilities of Streptococcus pneumoniae clinical isolates obtained in Canada in 2002.

Authors:  Jeff Powis; Allison McGeer; Karen Green; Otto Vanderkooi; Karl Weiss; George Zhanel; Tony Mazzulli; Magdalena Kuhn; Deirdre Church; Ross Davidson; Kevin Forward; Daryl Hoban; Andrew Simor; Donald E Low
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

8.  Multicentre study of the molecular epidemiology, serotypes and antimicrobial susceptibility patterns of invasive Streptococcus pneumoniae invasive isolated from children in the Ille de France area.

Authors:  J-W Decousser; P Ovetchkine; A Collignon; C Chaplain; E Estrangin; A Fremaux; P Reinert; P Foucaud; J-C Ghnassia; R Cohen; J Gaudelus; P-Y Allouch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-12-02       Impact factor: 3.267

9.  Emergence of Streptococcus pneumoniae with very-high-level resistance to penicillin.

Authors:  Stephanie J Schrag; Lesley McGee; Cynthia G Whitney; Bernard Beall; Allen S Craig; Miriam E Choate; James H Jorgensen; Richard R Facklam; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

10.  In vitro activities of garenoxacin (BMS-284756) against Streptococcus pneumoniae, viridans group streptococci, and Enterococcus faecalis compared to those of six other quinolones.

Authors:  Patrick Grohs; Serge Houssaye; Agnès Aubert; Laurent Gutmann; Emmanuelle Varon
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.